µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æרҵ£º 5Zuk`%O
aNUMF
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ js;k,`
W4q
|55
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) d]vom@iI
3w}ul~>j
1. ICAM-1 VQ;'SY:`
/HVxZ2bar
2. interleukin 12(IL-12) I#/"6%e
c)Ne/E{!0
3. tumor infiltrating lymphocyte [&pMU)
Ys]cJ]
4. TCR/CD3 complex nCDG PzJ
C6A!JegU
5. hematopoietin receptor family MIY`"h0*
',!>9Dj
6. individual idiotype(IdI) _wUg+Xs]
S5\KI+;PW
7. integrin nh? JiH
{
Q%W>m0%
8. colony-stimulatory factor (CSF) w\a6ga!xt"
ujf7r`;u.
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© wW7# M
jB,VlL
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? 1[!7xA0 j
[Pl''[
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ 8x-(7[#e<g
DDj:(I?,w
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷ÓᣠOVGB7CB]S
[-Xah]g
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØϵ¡£ I~4!8W-Y
\f7R^;`_<R
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) thz[h5C?C
eQ*zi9na
1. ÊÔÊö¸ÉÈÅËصķÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌص㡣Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËؼì²âµÄ·½·¨ºÍÔÀí¡£ bX
6uGu
7
BS%pS(
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ä¿Ç°¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æרҵ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) |Mgzb0_IiQ
lYmxd8
3. immunoglobulin superfamily (IgSF) .)<l69ZD Z
sQ+s3x1y
4. selectin ,y@WFRsx
q2s=>J';
5. anti-idiotypic antibody (¦ÁId) !x!1H5"
5!aI~(3<
6. major histocompatibility complex(MHC) +U4';[LG1C
s>
%.bAxc
7. immunotolerance v]rbm}uU9
P=7X+}@
8. biological reponse modifier(BRM) egH,7f(yP
WVz2 b zj
9. immune reponse gene (Ir gene) y`z4S,
/1_O5'5+v
10. reshaped antibody (or reconstituted antibody) sp+'c;a
^XG$?2<U
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© Q
g0%rbE
JJ'f\f9
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ qJ2Z5
Wf-XH|j[
2. ϸ°û¶¾ÐÔTÁÜ°Íϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? zF|c3ap
s3 fQGbU
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ R / ND f`
6:AEg
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? g<7Aln}Nl\
?uU_N$x
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ r4<As` &
4*IXBi7%
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? w'XN<RWA
/t! 5||G
2. Ä¿Ç°µ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ dp&G([
U| ?68B3
¹©Ïû»¯ÄÚ¿ÆרҵÊÔÌ⣺ 78 ]Kv^l^_
4O.R=c2}7>
1. Ä¿Ç°ÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? IP@3R(DS%
\)6bLB!
2. Ä¿Ç°µ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ SlHDBr!.z
/W .G-|:
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æרҵ: .lM]>y)
r=SCbv
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: q'4P/2)va
(:O6sTx-hE
̉񧄤 |"S#uJW
fM|s,'Q1x
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 6VuyKt
^fH)E"qq5
1. CD8 4_sJ0 =z-
[\Nmm4
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) -84%6p2-
iSR"$H{
3. immunoglobulin fold(Ig fold)
kPiY|EH
N~fE&@-
4. cadherin (Ca-dependent cell adhesion moleculers) kFY2VPP~
d*VvQU8C
5. idiotype-anti-idiotypic antibody immune network theory aXG|IN5 *m
I8% -ii
6. HLA class II antigen eThFRU3 F
%<+uJ'pj
7. complementarity-determining region (CDR) NZ&ZK@h}.
UNF\k1[
8. perforin(or pore-forming protein ,PFP) 2+DK:T[
EJMd[hMhe
9. high affinity IL-2 receptor e`H>}O/ai
%'_:#!9
10. artificial active immunization DpeJ
x
l&qyLL2
w
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© _b>{:H&\
>o v#\
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óᣠi+in?!@G:
qyFeq])
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 Eu~1t& 4
wIR"!C>LE
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£
E>i<2
vnVT0)Lel
4. ÊԱȽÏT¡¢BÁÜ°Íϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃ濹ԡ¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ rc<Ix
tKcC{
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐÑ¡Ò»Ìâ,3¡¢4ÌâÖÐÑ¡Ò»Ìâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ä¿Ç°¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ 3**t'iWQ
4e .19H9
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? |<,0
*2
(n:A`]
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ IHi[3xf<
(~{Y}n]s
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ ,%N[FZ`|
0A~UuH0.
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ !G[%; d
!9YCuHj!p
ѧ¿Æרҵ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ _->+Hjj ^
<;W-!R759
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© Gos#=H
cLwnV.
1. immunoglobulin gene rearrangement <fDT/
3 )#Nc|
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) +[MHl
P7,g^:$
3. flow cytometry(FCM) ;L -)$Dy4
s$fX
;
4. carrier effect {D..(f1*u
S2Ez}*plp
5. positive selection of T lymphocytes in thymus
] dJ"_
X])iQyN
6. mouse TH1(Th1) and TH2(Th2) subsets U?{oxy_[ 2
.*
9u_2<
7. perforin (pore-forming protein ,PFP) 0x5Ax=ut
W!O/t^H>
8. ADCC(antibody-dependent cell-mediated cytotoxicity) ercXw7{
ys`oHSf
9. SH-2(src-homology region 2) o/VT"cT
n
YUFRV$
10. Ab2¦Â (internal image) =M*pym]QSY
R_+:nCB@,
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© %PB{jo
1|xe'w{
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? L8h!%56s
Cx/J_Ro#
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? EwV$2AK
pKq[F*Lut
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦Óᣠ1?|"33\03R
fw,,cu`YA
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ %}zkmEY.e
pQ0*)}l,
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦Óᣠ{'M/wT)FeC
GeY!f/yQ<
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) gM;m{gXYK
FA{Q6fi:2
ÃâÒßѧרҵ£º @SxZ>|r-|v
XK/l1E3N
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ RDHK'PGA
Q0jg(=9wP
2. ÊԱȽÏÈËT¡¢BÁÜ°Íϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? F5cNF5
:P2!& W
´«È¾²¡Ñ§×¨Òµ£º W&9qgbO]
3]JJCaf
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦ÄÜ¿É·¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ }1k?t h
L(Twclrb
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØϵ¡£ O-UA2?N@j
q\i&ERr
Ïû»¯×¨Òµ£º ~%h
)G#N
_)= e`9%
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ }UGSE2^1
Pm2LB<qS
2.¼òÊöճĤÏà¹ØÁÜ°ÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌص㡣·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? Uq'W<.v5
u
e
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ
m5N,[^-
=e# h;x2
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© U.~G{H`G,u
s=jH1^
1. Fas(CD95)/FasL 9"S iHp\)
%$ o[,13=
2. common chain of cytokine receptor <aaT,J8%[
w<!,mL5 N
3 . TCR/CD3 complex ZEDvY=@a
AHuIA{AdUR
4. negaive selection of thymocytes #0h}{y
E
)XSHKPTQ1
5. artificial active immune T'lycc4~a
(m!kg
6. anti-idiotypic .7Yox1,
X8*~Cf73u
7. IgSF 4*f+np
5-fASN.Lx
8. Integrin 9wf"5c
v\G
7V
9. chemokine k_u!E3{~
Z
6Mjc/
10. B7/CD28 w]h8KNt
32aI0CT
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© [x,
`)Fk
& uwOyb
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ \X(*JNQ
zXlerQWUv
2. ±È½ÏCTLºÍNKɱÉË°Ðϸ°ûʱʶ±ðºÍɱÉË»úÖƵÄÌص㡣 sb_/F
E5e
-\%5aXr
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ j$6Q]5KdoS
WZ!zUUp}V
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆʵÑé·½°¸¿Ë¡´Ë»ùÒò¡£ U8>4Cl J4
vAop#V
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ v
\;/P
ct,;V/Dx
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ B9
?58v&
iYYuZ.
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© >tMI%r
%}~(%@qB>+
1. B7/CD28 g__s(
IJ
eYkg4 O'
2. Th1 subset Us#/#-hJ
87S,6 Y
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© [%6)
w03Ur4>T
4. antibody affinity maturation \=|=
(kt)
rxy5Nrue
5. AP-1 Ie _{P&J
WL,2<[)Ew
6. single chain variable fragment£¨ScFv£© D ZZRu8~
Xnh&Kyz`v
7. NK cell receptor <|G!Qn?2-
j5/|1N
8. Zinkernagel-Doherty phenomenon %2\Pe 2Z
v,~fG>Y}
9. Ig fold 1BEc"
QKVOc,Fp7i
10. CD40/CD40L @ %q>Jd
4!96k~d}
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© ;+o6"ky5
xA2I+r*o
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØϵ¡£ cud9oJ-=;
NZ!I >
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ B *6ncj
Kf$(7FT'`
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹Øϵ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ AkO);4A;Jd
uD{ xs
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ kv?DE4=;
ug;\`.nT^
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁÜ°Íϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ jr#*;go
<_=O0 t|6
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ OkT@ _U
&U}8@;
3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æרҵ£©¡£ w?N>3`Jnf
@k'V`ZQF
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£© <X& fs*x&
:mf&,?
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© oj'YDQ^uj
^si[L52BZ
1.Co-stimulators (or co-stimulating molecules) EymSrZw
>w.%KVBJ
2.NK-kB Cp>y<C"
S}]B |Q
3.Immunoglobulin superfamily n^5Q
f\ o
5gC>j(
4.antigen-presenting cell (APC) Zp<#( OIu
-XwS?*O
5.death domain `Gl[e4U
E_Y!in
70
6.CCR and CXCR MpJ<. |h
:7dc;WdM
7.Lectin (or mitogen) e5 zi "~
bs16G3-p
8.Clusters of differentiation, CD) hH%fWB2(
hJir_=
9.B7 family MLmaA3
se=^K#o
10.Cytotoxic T lymphocyte, CTL) \ n^[!e"`
u!F\`Gfm_
11.IL-15 and IL-15 receptor (IL-15R) k"/Rjd(;
IXm[c@5l
12.MHC restriction wrX n|aV
3#>%_
@<
13.Affinity-chromatography y
c 8h}`
MEp{v|1
14.Cyctosprin A, CsA 9$C?)XKXB
DQ[7p(
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) ?.lo[X<,*
qK9A
/Mc
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© u%I%4 gM
LXhR"PWZM\
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 "zCT S
b0f6p>~q^
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ 8c_X`0jy
uGqeT#dP
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌص㡣 i1m>|[@k
"bWx<
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© 4gNN "
2 >j0,2
ÃâÒßѧרҵ£º s8P3H|0.-
l(}L-:@A
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ / #rH18
OJJ [Er1
Ïû»¯ÄÚ¿Æ£º 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ v-q-CI?B#
fiD,HGx
i
ѪҺ²¡Ñ§×¨Òµ£º 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿ ',t*:GBZCf
{2D|,yH=
Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ (רҵ»ù´¡: ÃâÒßѧ) CYwV]lq:s
Tcc83_Iq
Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö) J[hmY= ,
!J X7y%J
1. ADCC(antibody dependent cell-mediated cytotoxicity) [[6"qq
RjPkH$u'Pj
2. »·æß¾úËØ(cyclosporin) ?CC.xE
-o`K/f}
d
3. KIR(killer cell inhibitory receptor) Q@>1z*'I
Qzo -Yw`=
4. HLDA(human leucocyte differentiation antigen) xU0iz{9
U1E@pDH
5. Interleukin 18(IL-18) ~_ZK93o(
?<
teHFj
6. ÕûºÏËØ(integrin) 3\
Mt+!1{
D6&P9e_5
7. Fas/FasL DrV[1Z
x$n.\`f0
8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå) ipp`9 9
Us'JMZ~
9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM) 7 vFmB
HJ]e%og
10. Th1/Th2 .S#i/A'x
Sk!' 2y*@&
11. »ùÒòÒßÃç(DNAÒßÃç) (@xC-*
]GY8f3~|{
12. chemokines and chemokine receptor xZ;eV76
~K3Lbd|
r
13. ÃâÒßÄÍÊÜ eaDZ^Z
Er
|UWIV
14. ¹²´Ì¼¤·Ö×Ó /*Q3=Dse]
g_P98_2f.k
15. ËÀÍö½á¹¹Óò(death domain) __QnzEF
||pOiR5
¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö) e.DN,rhqI
&ZC{ _t
1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉË°Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬? 6O6B8
`Kf@<=
2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»Æƶø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óᣠ*qSvSY*
}(Fmr7%m
£¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î zc;kNkV#1Y
k# Ho7rS&
£¨2£©1977Ä꣺·ÅÉäÃâÒß·¨ ),B/NZ/
-
R--s
u:
£¨3£©1984Ä꣺ÁÜ°Íϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå 5~DKx7P!Z
XfVdYmii
£¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹ 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄЩÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£ hN=kU9@knC
gsM$VaF(
Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ) ÎÊ´ðÌâ(ÿÌâ25·Ö) y< dBF[
2INpo
1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£ JB'tc!!*
_oBx:G6E
2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿ UF5_be,D
NwYQ6VEA
3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆһϵͳʵÑé,¼ÓÒÔ֤ʵ¡£ 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃÇ°¾°¡£